Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, today announces that it has raised £35.5 million ($45.4 million) of new capital in a Series B financing round. Redmile Group led the [...]
Compass Therapeutics, a biotechnology company committed to the ambitious goal of comprehensively drugging the human immune system, today announced the closing of the final $49 million of its $132 million Series A financing. This financing [...]
Autodesk has made a name for itself among designers, engineers and architects with its 3D and other modelling software. Now, as it continues to build out its business in adjacent business areas like construction, it [...]
Orbit Discovery Ltd, an Oxford, UK-based biotech company developing an industry-leading peptide identification and optimisation platform, today announced the closing of a £6.9M Series A Financing. The round was led by Oxford Sciences Innovation who [...]
For over a decade and a half, the Built Environment Investment Team at Borealis Ventures has been funding and mentoring firms ready to build a better world. As the portfolio and market demand continued to grow, the decision to create a new dedicated venture strategy was a natural one. In 2018, we decided to leverage all of the expertise from the Borealis Ventures Built Environment Investment Team and give it even greater focus by forming Building Ventures, entirely committed to funding disruptive ideas in the built environment for a better built world.
We’re always interested in engaging with inventors, creators, and entrepreneurs to help develop ideas and realize visions.